Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Mid-America Apartment Communities
MAA
$15.5B
| $38.4M | 0.05% |
372,446
-8,124
| -2% | -$1.06M |
|
|
MDRX
177
DELISTED
Veradigm Inc. Common Stock
MDRX
| $37.5M | 0.05% |
5,329,691
+29,579
| +0.6% | +$240K |
|
178
Regal Rexnord
RRX
$11.9B
| $37.1M | 0.05% |
589,776
-45,465
| -7% | -$3.57M |
|
179
Charles River Laboratories
CRL
$12.7B
| $37.1M | 0.05% |
293,711
-53,851
| -15% | -$8.08M |
|
180
East-West Bancorp
EWBC
$18.1B
| $36.9M | 0.05% |
1,434,050
-97,567
| -6% | -$4.06M |
|
181
Goldman Sachs
GS
$301B
| $36.7M | 0.05% |
237,666
-14,189
| -6% | -$3.01M |
|
182
iShares Global Energy ETF
IXC
$2.78B
| $36.1M | 0.04% |
2,137,465
-249,662
| -10% | -$6.23M |
|
183
Cleveland-Cliffs
CLF
$6.98B
| $36.1M | 0.04% |
9,129,022
-790,743
| -8% | -$4.97M |
|
184
Stratasys
SSYS
$760M
| $35.6M | 0.04% |
2,229,123
-142,748
| -6% | -$2.6M |
|
185
Darling Ingredients
DAR
$9.62B
| $35M | 0.04% |
1,824,497
-126,162
| -6% | -$3.2M |
|
186
Azenta
AZTA
$1.42B
| $34.7M | 0.04% |
1,137,898
-47,025
| -4% | -$1.71M |
|
187
Emergent Biosolutions
EBS
$272M
| $33.9M | 0.04% |
585,958
-45,026
| -7% | -$2.59M |
|
188
Integra LifeSciences
IART
$1.33B
| $31.8M | 0.04% |
711,982
+14,272
| +2% | +$749K |
|
|
UMPQ
189
DELISTED
Umpqua Holdings Corp
UMPQ
| $31.6M | 0.04% |
2,896,821
-45,650
| -2% | -$710K |
|
190
Plexus
PLXS
$7.18B
| $31.6M | 0.04% |
578,382
-69,342
| -11% | -$4.68M |
|
191
Diageo
DEO
$51.6B
| $31.4M | 0.04% |
247,248
-12,028
| -5% | -$1.8M |
|
192
Boeing
BA
$184B
| $31.1M | 0.04% |
208,355
-3,584
| -2% | -$981K |
|
193
Artisan Partners
APAM
$3.06B
| $30.1M | 0.04% |
1,402,314
-77,235
| -5% | -$2.32M |
|
194
Prestige Consumer Healthcare
PBH
$2.58B
| $29.9M | 0.04% |
816,121
+1,774
| +0.2% | +$68.9K |
|
195
Biogen
BIIB
$30.5B
| $29.6M | 0.04% |
93,625
+2,848
| +3% | +$864K |
|
196
Knowles
KN
$3.36B
| $28.5M | 0.04% |
2,132,366
+1,117,546
| +110% | +$19.4M |
|
197
Terex
TEX
$7.47B
| $28.3M | 0.04% |
1,971,114
-143,756
| -7% | -$3.26M |
|
198
Lazard
LAZ
$4.22B
| $28.1M | 0.03% |
1,191,944
-64,894
| -5% | -$2.4M |
|
199
Medpace
MEDP
$16.3B
| $27.7M | 0.03% |
378,136
-38,402
| -9% | -$3.33M |
|
|
COR
200
DELISTED
Coresite Realty Corporation
COR
| $27.3M | 0.03% |
235,241
-3,325
| -1% | -$370K |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.